Hexagon Bio

📍 Menlo Park, United States👥 87 employees💰 Last funded Jun 2021
Biotechnology Research🌐 hexagonbio.com
Website LinkedIn
Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics. Our proprietary platform combines data science, genomics, synthetic biology, chemistry and automation to discover potent, evolutionarily-refined small molecules and their cognate targets directly from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Switzerland
1
Investor activity2017–2021 · investors recorded per year
201722020120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Hexagon Bio?
Hexagon Bio has 4 investors on record on gritt.io.
When did Hexagon Bio last raise funding?
The most recent investment in Hexagon Bio recorded on gritt.io was in June 2021.
What industry is Hexagon Bio in?
Hexagon Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Hexagon Bio based?
Hexagon Bio is headquartered in Menlo Park, United States.